Senior insider sale
Chief Scientific Officer at NUVALENT, INC. — senior position signals high conviction
$4.32M
43.36K shares
What this filing means
PELISH HENRY E. plans to sell 43.36K shares of NUVALENT, INC. valued at approximately $4.32M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/12/2026ACC: 0001950047-26-002552
Officer· Chief Scientific Officer
Since Mar 2026
43.36K
Shares to sell
$4.32M
Approx. market value
38.20K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months3
Exercise of Stock Options
Cash
3/12/2026
20.41KRestricted Stock Units
N/A
1/5/2025
4.25KPreviously Exercised Stock Options
Cash
12/16/2024
13.53KTotal acquired38.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/12/2026 | Exercise of Stock Options Cash | 20.41K | — |
1/5/2025 | Restricted Stock Units N/A | 4.25K | — |
12/16/2024 | Previously Exercised Stock Options Cash | 13.53K | — |
| Total | 38.20K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.66K
Market value
$258.8K
1/6/2026
—Completed
Units to sell
2.50K
Market value
$242.9K
1/5/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
38.20K
Market value
$3.82M
3/12/2026
Total
Units
43.36K
Value
$4.32M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/6/2026 | 2.66K | $258.8K | — | Completed |
1/5/2026 | 2.50K | $242.9K | — | Completed |
| Planned — Approximate Date | ||||
3/12/2026 | 38.20K | $3.82M | NASDAQ | Planned |
| Total | 43.36K | $4.32M | ||